Literature DB >> 28697271

Encouraging long-term outcomes reported in patients with stage I non-small cell lung cancer treated with stereotactic ablative radiotherapy.

Mary Kay Barton.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28697271     DOI： 10.3322/caac.21375

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  7 in total

1.  High level of FHL2 exacerbates the outcome of non-small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells.

Authors:  Na Li; Ling Xu; Ji Zhang; Yongyu Liu
Journal:  Int J Exp Pathol       Date:  2022-04-02       Impact factor: 2.793

Review 2.  AFAP1-AS1: A novel oncogenic long non-coding RNA in human cancers.

Authors:  Fuyou Zhang; Jianfa Li; Huizhong Xiao; Yifan Zou; Yuchen Liu; Weiren Huang
Journal:  Cell Prolif       Date:  2017-10-22       Impact factor: 6.831

3.  The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in non-small cell lung cancer.

Authors:  Xiaoyuan Wang; Hang Yin; Luquan Zhang; Dayong Zheng; Yingnan Yang; Jinfeng Zhang; Hao Jiang; Xiaodong Ling; Yanzhong Xin; Hao Liang; Chengyuan Fang; Jianqun Ma; Jinhong Zhu
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

4.  An Anti-Cancer Peptide LVTX-8 Inhibits the Proliferation and Migration of Lung Tumor Cells by Regulating Causal Genes' Expression in p53-Related Pathways.

Authors:  Peng Zhang; Yujie Yan; Junting Wang; Xiaoping Dong; Gaihua Zhang; Yong Zeng; Zhonghua Liu
Journal:  Toxins (Basel)       Date:  2020-06-02       Impact factor: 4.546

5.  UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.

Authors:  Dan Jin; Jiwei Guo; Yan Wu; Jing Du; Xiaohong Wang; Jiajia An; Baoguang Hu; Lingqun Kong; Weihua Di; Wansheng Wang
Journal:  Theranostics       Date:  2019-03-17       Impact factor: 11.556

6.  Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5).

Authors:  Yi Li; Xiaojuan Yang; Dan Lu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

7.  The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.

Authors:  Jiwei Guo; Dan Jin; Yan Wu; Lijuan Yang; Jing Du; Kaikai Gong; Weiwei Chen; Juanjuan Dai; Shuang Miao; Sichuan Xi
Journal:  EBioMedicine       Date:  2018-08-23       Impact factor: 8.143
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.